Meeder Asset Management’s THERAGENICS CORP TGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-1,750
Closed -$4K 405
2013
Q3
$4K Hold
1,750
﹤0.01% 336
2013
Q2
$4K Buy
+1,750
New +$3.13K ﹤0.01% 341

Meeder Asset Management's TGX Position: Q4 2013 in Review

Meeder Asset Management sold out of THERAGENICS CORP (TGX) in Q4 2013, closing a stake of 1,750 shares — an estimated $4K sold.

Meeder Asset Management first reported a position in TGX in Q2 2013 and held it in 2 quarters. The position peaked at $4K in Q3 2013. 0 funds tracked by Wall St. Rank hold TGX as of Q4 2013.

  • Meeder Asset Management reported no remaining THERAGENICS CORP position as of Q4 2013 after selling out during the quarter.
  • Meeder Asset Management sold 1,750 THERAGENICS CORP shares in Q4 2013, an estimated $4K.
  • Meeder Asset Management first reported a position in THERAGENICS CORP in Q2 2013 and held it in 2 quarters.
  • Meeder Asset Management's THERAGENICS CORP position peaked at $4K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held THERAGENICS CORP as of Q4 2013.

Based on Meeder Asset Management's 13F filing for Q4 2013, filed 28 Jan 2014.